Dupixent (dupilumab) - Sanofi, Regeneron
Enterobiasis Associated with Dupilumab Treatment for Eosinophilic Esophagitis (ACAAI 2026) - Oct 28, 2026 - Abstract #M156; Pres time: Nov 14, 2026; 12:30 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 3; No abstract available 
Eosinophilic Esophagitis • Gastrointestinal Disorder • Immunology
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next